{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Advances in Pediatric Acute Lymphoblastic Leukemia
Activity Steps
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Purpose of Activity
To provide information about the latest advances in pediatric acute lymphoblastic leukemia.Learning Objectives
After completing this continuing education activity you will be able to:
- Identify the incidence of acute lymphoblastic leukemia (ALL) and techniques for diagnosing the disease.
- Distinguish characteristics of ALL subtypes, including associated patient prognoses.
Disclosures
The author(s), faculty, staff, and planners, including spouses/partners (if any), in any position to control the content of this activity, have disclosed that they have no financial relationships with, or financial interests in, any commercial companies relevant to this educational activity.
Price:
$12.95
Credits:
- ANCC 1.0 CH
- DC - BON 1.0 CH
- FL - BON 1.0 CH
- GA - BON 1.0 CH
Lippincott Professional Development is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223.
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Test Code: OT1220
Published: December 2020
Expires: 12/6/2024
Sources:
Oncology Times
Required Passing Score: 8/10 (80%)